AstraZeneca has been ordered to pay $107.5 million to Pfizer in damages for infringing Pfizer’s patents, GlobalData reported May 20.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
AstraZeneca to pay $107.5M for cancer drug patent infringement
